Home LiteratureArticle Details
PMID: 16818676 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.

The Journal of experimental medicine ·Vol. 203 ·No. 7 ·2006-07-10 ·Pages 1693-700

Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B

Abstract

Abnormalities in CD4(+)CD25(+)Foxp3(+) regulatory T (T reg) cells have been implicated in susceptibility to allergic, autoimmune, and immunoinflammatory conditions. However, phenotypic and functional assessment of human T reg cells has been hampered by difficulty in distinguishing between CD25-expressing activated and regulatory T cells. Here, we show that expression of CD127, the alpha chain of the interleukin-7 receptor, allows an unambiguous flow cytometry-based distinction to be made between CD127(lo) T reg cells and CD127(hi) conventional T cells within the CD25(+)CD45RO(+)RA(-) effector/memory and CD45RA(+)RO(-) naive compartments in peripheral blood and lymph node. In healthy volunteers, peripheral blood CD25(+)CD127(lo) cells comprised 6.35 +/- 0.26% of CD4(+) T cells, of which 2.05 +/- 0.14% expressed the naive subset marker CD45RA. Expression of FoxP3 protein and the CD127(lo) phenotype were highly correlated within the CD4(+)CD25(+) population. Moreover, both effector/memory and naive CD25(+)CD127(lo) cells manifested suppressive activity in vitro, whereas CD25(+)CD127(hi) cells did not. Cell surface expression of CD127 therefore allows accurate estimation of T reg cell numbers and isolation of pure populations for in vitro studies and should contribute to our understanding of regulatory abnormalities in immunopathic diseases.

MeSH Terms
Adult Humans Infant, Newborn Lymphocyte Activation/immunology Receptors, Interleukin-2/biosynthesis,genetics Receptors, Interleukin-7/biosynthesis,genetics T-Lymphocyte Subsets/immunology,metabolism T-Lymphocytes, Regulatory/immunology,metabolism
Chemicals
Receptors, Interleukin-2 Receptors, Interleukin-7
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Seddiki Nabila
Centenary Institute of Cancer Medicine and Cell Biology, Faculty of Medicine, University of Sydney, Newtown, NSW 2042, Australia.
Santner-Nanan Brigitte
Martinson Jeff
Zaunders John
Sasson Sarah
Landay Alan
Solomon Michael
Selby Warwick
Alexander Stephen I
Nanan Ralph
Kelleher Anthony
Fazekas de St Groth Barbara
References (29)
29 references, click to expand
  1. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.
    Nat Immunol. 2002 Jan;3(1):33-41 PMID: 11740498
  2. CD4+CD25high regulatory cells in human peripheral blood.
    J Immunol. 2001 Aug 1;167(3):1245-53 PMID: 11466340
  3. Quantification of regulatory T cells in patients with systemic lupus erythematosus.
    J Autoimmun. 2003 Nov;21(3):273-6 PMID: 14599852
  4. Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells.
    J Immunol. 2003 Dec 1;171(11):5678-82 PMID: 14634074
  5. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.
    Lancet. 2004 Feb 21;363(9409):608-15 PMID: 14987885
  6. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs.
    J Clin Immunol. 2004 Mar;24(2):155-61 PMID: 15024182
  7. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.
    Annu Rev Immunol. 2004;22:531-62 PMID: 15032588
  8. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy.
    Scand J Immunol. 2004 Apr;59(4):408-14 PMID: 15049785
  9. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.
    J Exp Med. 2004 Apr 5;199(7):971-9 PMID: 15067033
  10. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II.
    J Exp Med. 2004 May 3;199(9):1285-91 PMID: 15117972
  11. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy.
    J Exp Med. 2004 Jun 21;199(12):1679-88 PMID: 15197226
  12. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease.
    Arthritis Res Ther. 2004;6(4):R335-46 PMID: 15225369
  13. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy.
    J Exp Med. 2004 Aug 2;200(3):277-85 PMID: 15280421
  14. CD25+CD4+ regulatory T cells in patients with Kawasaki disease.
    J Pediatr. 2004 Sep;145(3):385-90 PMID: 15343196
  15. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
    Arthritis Rheum. 2004 Sep;50(9):2775-85 PMID: 15457445
  16. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.
    Cell. 1993 Oct 22;75(2):253-61 PMID: 8402910
  17. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
    J Exp Med. 1995 Apr 1;181(4):1519-26 PMID: 7699333
  18. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.
    J Immunol. 2005 Jan 1;174(1):164-73 PMID: 15611238
  19. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.
    Hum Immunol. 2005 Jan;66(1):13-20 PMID: 15620457
  20. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
    Blood. 2005 Jan 15;105(2):750-8 PMID: 15374887
  21. FOXP3 acts as a rheostat of the immune response.
    Immunol Rev. 2005 Feb;203:156-64 PMID: 15661028
  22. Development and activation of regulatory T cells in the human fetus.
    Eur J Immunol. 2005 Feb;35(2):383-90 PMID: 15682453
  23. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia.
    J Exp Med. 2005 Jun 6;201(11):1793-803 PMID: 15939793
  24. A peripheral circulating compartment of natural naive CD4 Tregs.
    J Clin Invest. 2005 Jul;115(7):1953-62 PMID: 16007258
  25. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.
    Eur J Immunol. 2005 Jun;35(6):1681-91 PMID: 15902688
  26. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.
    J Clin Invest. 2005 Nov;115(11):3276-84 PMID: 16211090
  27. Persistence of naive CD45RA+ regulatory T cells in adult life.
    Blood. 2006 Apr 1;107(7):2830-8 PMID: 16332974
  28. MHC class II expression identifies functionally distinct human regulatory T cells.
    J Immunol. 2006 Apr 15;176(8):4622-31 PMID: 16585553
  29. Multiple immuno-regulatory defects in type-1 diabetes.
    J Clin Invest. 2002 Jan;109(1):131-40 PMID: 11781358
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2006-07-10
Epub
2006-00-03
Pages
1693-700
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118333
Subset
IM
Grants
NIAID NIH HHS · P01 AI055793 · United States
NIAID NIH HHS · U19 AI055793 · United States
NIAID NIH HHS · AI 55793 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]